Colin Berry

• Consultant Cardiologist at:

  • Golden Jubilee National Hospital, Clydebank, Scotland (present)

  • Queen Elizabeth University Hospital, Glasgow, Scotland (present)

  • Ross Hall Hospital, Glasgow, Scotland (present)

  • Ross Hall Clinic Braehead, Renfrew, Scotland (present)

  • Nuffield Health Glasgow Hospital, Glasgow, Scotland (present)

• Director of Research at the School of Cardiovascular and Metabolic Health, University of Glasgow

• Executive Editor of the European Heart Journal

• President of the British Society of Cardiovascular Magnetic Resonance (2022–2024)

• Steering Group Member of the International Coronary Vasomotor Disorders International Study Group (COVADIS)

• Founder of the British Cardiovascular Society Working Party for Ischaemic Heart Disease (2023)

• • Ischaemic heart disease (angina, heart attack, heart failure)

  • Small vessel disease (heart and brain)

  • Therapy development

  • Injury and repair pathways in heart attack and heart failure

  • Coronary microvascular dysfunction (MINOCA, INOCA)

  • Long COVID-19 cardiovascular complications

• Notable Studies:

  • CorMicA Trial: Led the world-first study mapping heart attack injury using MRI, funded by the British Heart Foundation and Siemens Healthineers

  • CorCTCA, CorCMR, CorPEF, iCorMicA, PRIZE, StratMed-MINOCA: Ongoing studies focusing on coronary microvascular angina and precision medicine

• 2014: Marshall Research Excellence Prize, British Society of Cardiovascular Research

• 2019: European Research Award, EuroPCR

• 2020: BCIS Research Award

• 2022: British Cardiovascular Society Best Abstract Award

• 2013: Inspiring City Award, University of Glasgow

Colin Berry is a Consultant Cardiologist and Professor of Cardiology and Imaging at the University of Glasgow, with over 30 years of experience in the medical field. He specializes in imaging and interventional cardiology, focusing on microvascular and ischaemic heart diseases. Professor Berry has pioneered several innovative techniques, including the use of MRI to map heart attack injury and the introduction of coronary artery optical coherence tomography into the NHS. He leads a research group dedicated to understanding and treating coronary microvascular dysfunction and has contributed to multiple clinical trials and studies on cardiovascular health.